Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cavilon vs Sorbolene in Post-Mastectomy Irradiation Skin Care
NCT00193908Phase 3Completed
- Sponsor
- Trans-Tasman Radiation Oncology Group
- Start
- Mar 2004
- Primary completion
- Sep 2007
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of Cavilon Durable Barrier Cream in radiation dermatitis, sponsored by Trans-Tasman Radiation Oncology Group. Started Mar 2004; status: completed.
02
Drugs
Cavilon Durable Barrier Cream
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT00193908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193908.